3,375
Views
0
CrossRef citations to date
0
Altmetric
Urology

Translating the efficacy of dapagliflozin in chronic kidney disease to lower healthcare resource utilization and costs: a medical care cost offset analysis

, , , , , , , , , & ORCID Icon show all
Pages 1407-1416 | Received 09 Aug 2023, Accepted 26 Sep 2023, Published online: 31 Oct 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.